Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females.
Response of iron, copper, and zinc status to supplementation with Zn or a combination of Zn and Fe was assessed in adult females in a 10-wk study. Group Z received 50 mg Zn/d as Zn gluconate; group F-Z received 50 mg Fe as ferrous sulfate monohydrate in addition to the Zn. For Group Z, serum ferritin, hematocrit, and erythrocyte Cu,Zn-superoxide dismutase (ESOD) were significantly lower (p less than 0.05) after 10 wk supplementation compared with pretreatment levels. Serum Zn increased (p less than 0.01) but no change occurred in serum ceruloplasmin, hemoglobin, or salivary sediment Zn with treatment. For Group F-Z ESOD decreased with treatment as did salivary sediment Zn (p less than 0.05). Serum ferritin and serum Zn increased significantly, but hemoglobin, hematocrit, and ceruloplasmin were not affected by this treatment. Supplementation with Zn poses a risk to Fe and Cu status. Inclusion of Fe with Zn ameliorates the effect on Fe but not on Cu status.
Yadrick
M K
MK
Department of Food, Nutrition, Oklahoma State University, Stillwater.
Kenney
M A
MA
Winterfeldt
E A
EA
D000328:Adult; D001665:Binding Sites; D001667:Binding, Competitive; D003300:Copper / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005293:Ferritins / Q000032:analysis; D005527:Food, Fortified; D006400:Hematocrit; D006801:Humans; D007501:Iron / Q000008:administration & dosage / Q000097:blood*; D013482:Superoxide Dismutase / Q000097:blood; D015032:Zinc / Q000008:administration & dosage / Q000097:blood*
D003300:Copper; D005293:Ferritins; D007501:Iron; D013482:Superoxide Dismutase; D015032:Zinc